| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Obstetrics and Gynecology, Kanazawa University, School of Medicine, Kanazawa Ishikawa 920-8641 [Z. W., S. K., M. Tak., M. Tan., N. Y., Y. M., K. K., M. I.]; Department of 1st surgery, Okayama University, School of Medicine, Okayama 700-8558 [M. F.]; and Department of Obstetrics and Gynecology, Osaka University Medical School, Osaka 565-0871 [J. H., M. O.], Japan
Emerging evidence indicates that sex steroid hormones regulate telomerase in target tissues. We have reported that estrogen activates telomerase through transactivation of the telomerase catalytic subunit, human telomerase reverse transcriptase (hTERT). Progesterone usually antagonizes estrogen action in reproductive organs, but the effect on telomerase remains unclear. In this study, we examine the effects of progesterone on the gene expression of hTERT in breast and endometrial cancer cell lines expressing progesterone receptor. Progesterone significantly induced hTERT mRNA expression within 3 h after exposure. This transient effect peaked at 12 h and then decreased. In contrast, exposure to progesterone for >48 h antagonized estrogen effects and inhibited the estrogen-induced activation of hTERT expression; the cyclin-dependent kinase inhibitor p21/Waf1/Cip1 plays an integral role in this inhibition. Thus, progesterone exerts diverse effects on hTERT mRNA expression in a time-dependent manner. We also found that the mitogen-activated protein kinase signaling pathway mediates both the short-term and long-term effects of progesterone on hTERT gene expression. These findings support the notion that hTERT gene is a target of both estrogen and progesterone.
This article has been cited by other articles:
![]() |
Hu Jian, Sun Li, Zhang Chong, and X.-L. Zhou Expression of Telomeric Repeat Binding Factor 1 Protein in Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive International Journal of Surgical Pathology, October 1, 2008; 16(4): 414 - 418. [Abstract] [PDF] |
||||
![]() |
D.K. Hapangama, M.A. Turner, J.A. Drury, S. Quenby, G. Saretzki, C. Martin-Ruiz, and T. Von Zglinicki Endometriosis is associated with aberrant endometrial expression of telomerase and increased telomere length Hum. Reprod., July 1, 2008; 23(7): 1511 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Yoshimura, T Sumida, S Liu, A Onishi, S Shintani, P-Y Desprez, and H Hamakawa Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment Endocr. Relat. Cancer, December 1, 2007; 14(4): 1107 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Russo, P. Berardinelli, A. Martelli, O. Di Giacinto, D. Nardinocchi, D. Fantasia, and B. Barboni Expression of Telomerase Reverse Transcriptase Subunit (TERT) and Telomere Sizing in Pig Ovarian Follicles J. Histochem. Cytochem., April 1, 2006; 54(4): 443 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saitoh, M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, M. Doshida, T. Takahashi, H. Igarashi, A. Mori-Abe, B. Du, et al. Medroxyprogesterone Acetate Induces Cell Proliferation through Up-Regulation of Cyclin D1 Expression via Phosphatidylinositol 3-Kinase/Akt/Nuclear Factor-{kappa}B Cascade in Human Breast Cancer Cells Endocrinology, November 1, 2005; 146(11): 4917 - 4925. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawauchi, K. Ihjima, and O. Yamada IL-2 Increases Human Telomerase Reverse Transcriptase Activity Transcriptionally and Posttranslationally through Phosphatidylinositol 3'-Kinase/Akt, Heat Shock Protein 90, and Mammalian Target of Rapamycin in Transformed NK Cells J. Immunol., May 1, 2005; 174(9): 5261 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sumida, Y. Itahana, H. Hamakawa, and P.-Y. Desprez Reduction of Human Metastatic Breast Cancer Cell Aggressiveness on Introduction of Either Form A or B of the Progesterone Receptor and Then Treatment with Progestins Cancer Res., November 1, 2004; 64(21): 7886 - 7892. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amini, M. Saunders, K. Kelley, K. Khalili, and B. E. Sawaya Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes J. Biol. Chem., October 29, 2004; 279(44): 46046 - 46056. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kyo, M. Nakamura, T. Kiyono, Y. Maida, T. Kanaya, M. Tanaka, N. Yatabe, and M. Inoue Successful Immortalization of Endometrial Glandular Cells with Normal Structural and Functional Characteristics Am. J. Pathol., December 1, 2003; 163(6): 2259 - 2269. [Abstract] [Full Text] |
||||
![]() |
I. Horikawa and J. C. Barrett Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fu, C. Lu, and M. P. Mattson Telomerase Mediates the Cell Survival-Promoting Actions of Brain-Derived Neurotrophic Factor and Secreted Amyloid Precursor Protein in Developing Hippocampal Neurons J. Neurosci., December 15, 2002; 22(24): 10710 - 10719. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kumaki, K. Takeda, Z.-X. Yu, J. Moss, and V. J. Ferrans Expression of Human Telomerase Reverse Transcriptase in Lymphangioleiomyomatosis Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 187 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Mauro and D. N. Foster Regulators of Telomerase Activity Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 521 - 524. [Full Text] [PDF] |
||||
![]() |
K. Nomoto, M. Maekawa, K. Sugano, M. Ushiama, N. Fukayama, S. Fujita, and T. Kakizoe Methylation Status and Expression of Human Telomerase Reverse Transcriptase mRNA in Relation to Hypermethylation of the p16 gene in Colorectal Cancers as Analyzed by Bisulfite PCR-SSCP Jpn. J. Clin. Oncol., January 1, 2002; 32(1): 3 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Komata, Y. Kondo, T. Kanzawa, S. Hirohata, S. Koga, H. Sumiyoshi, S. M. Srinivasula, B. P. Barna, I. M. Germano, M. Takakura, et al. Treatment of Malignant Glioma Cells with the Transfer of Constitutively Active Caspase-6 Using the Human Telomerase Catalytic Subunit (Human Telomerase Reverse Transcriptase) Gene Promoter Cancer Res., August 1, 2001; 61(15): 5796 - 5802. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |